Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis
Clinical trial NCT00819195 · COMPLETED
Trial details
- NCT number
- NCT00819195
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-12-01
- Primary completion
- 2012-09-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.